Mutations that encode for nonsense codons result in truncated proteins that don’t function properly, leading to many different diseases. PTC Therapeutics, a startup in South Plainfield, NJ, has developed a new drug that allows the cell to skip over these nonsense codons to produce functional proteins, thereby treating the disease's cause, not just symptoms.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.